Erosive Esophagitis: Clinical Trials

4 trials for Erosive Esophagitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 1 recruiting. 4 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable4Unknown 3, Recruiting 1

Follow Erosive Esophagitis: new trials by email Literature Review of Erosive Esophagitis trials Research Report on Erosive Esophagitis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment Effect According to Timing of Administration of DWP14012 40 mg
DWP14012 - Erosive Esophagitis
Not applicableUnknownKonkuk University Medical Center1862021-02-012021-05-17
Treatment Effect According to Timing of Administration of DWP14012 40 mg
DWP14012 - Erosive Esophagitis
Not applicableUnknownDaewoong Pharmaceutical Co. LTD.1862020-11-172020-11-03
Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adherence
diet adherence, No diet adherence, Change in physical activity - Gastroesophageal Reflux Disease, GERD
Not applicableRecruitingFederal State Budgetary Scientific Institution1502020-01-312025-08-03
Confocal Endomicroscopy for Permeability of Esophageal Wall in Refractory Gastroesophageal Reflux Disease (GERD)
Confocal endomicroscopy, Endoscopic biopsies, Mucosal impedance (MI) - Gastro Esophageal Reflux, Barrett Esophagus
Not applicableUnknownMcGuire Research Institute602017-04-282018-01-16

Narrower conditions

Gastroesophageal Reflux (2)  ·  Barrett Esophagus (1)  ·  Non-Erosive Reflux Disease (1)

Broader conditions

Deglutition Disorders (2)  ·  Digestive System Diseases (2)  ·  Esophageal Diseases (2)  ·  Esophageal Motility Disorders (2)  ·  Gastrointestinal Diseases (2)  ·  Neoplasms (1)  ·  Precancerous Conditions (1)

Interventions

fexuprazan (2)  ·  Endoscopic Mucosal Resection (1)  ·  Exercise (1)

Sponsors

Daewoong Pharmaceutical Co. LTD. (1)  ·  Federal State Budgetary Scientific Institution (1)  ·  Konkuk University Medical Center (1)  ·  McGuire Research Institute (1)

Countries

South Korea (2)  ·  Russia (1)  ·  United States (1)

Top investigators

Sergey Morozov, MD, PhD (1)

Results publications

PMID 20626453, PMID 22415199, PMID 8898633